Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Nuclear Medicine and Biology|August 18, 2020
GMP production of [68Ga]Ga-BOT5035 for imaging of liver fibrosis in microdosing phase 0 studyIrina Velikyan, Johan G Doverfjord, Sergio Estrada, et al.
Theranostics|July 9, 2019
Regularized reconstruction of digital time-of-flight 68Ga-PSMA-11 PET/CT for the detection of recurrent disease in prostate cancer patientsElin Lindström, Irina Velikyan, Naresh Regula, et al.
Analytical Chemistry|February 1, 2005
Polyamine deactivation of integrated poly(dimethylsiloxane) structures investigated by radionuclide imaging and capillary electrophoresis experimentsSara K Bergström, Niklas Edenwall, Martin Lavén, et al.
Nuclear Medicine and Biology|July 1, 2008
The importance of high specific radioactivity in the performance of 68Ga-labeled peptideIrina Velikyan, Gerd J Beyer, Elisabeth Bergström-Pettermann, et al.
Nuclear Medicine and Biology|January 19, 2024
Introduction of a fatty acid chain modification to prolong circulatory half-life of a radioligand towards glucose-dependent insulinotropic polypeptide receptorAmina Khalil, Sona Hakhverdyan, Pierre Cheung, et al.
Nuclear Medicine and Biology|December 6, 2011
Preclinical evaluation of a 68Ga-labeled biotin analogue for applications in islet transplantationOlof Eriksson, Fredrik Carlsson, Elisabeth Blom, et al.
Nuclear Medicine and Biology|July 16, 2014
Synthesis and preclinical evaluation of 68Ga-labeled collagelin analogs for imaging and quantification of fibrosisIrina Velikyan, Ulrika Rosenström, Sergio Estrada, et al.
EJNMMI Research|March 31, 2021
Prospective data-driven respiratory gating of [68Ga]Ga-DOTATOC PET/CTJonathan Sigfridsson, Elin Lindström, Victor Iyer, et al.
American Journal of Nuclear Medicine and Molecular Imaging|March 27, 2019
Diagnostic HER2-binding radiopharmaceutical, [68Ga]Ga-ABY-025, for routine clinical use in breast cancer patientsIrina Velikyan, Philip Schweighöfer, Joachim Feldwisch, et al.
American Journal of Nuclear Medicine and Molecular Imaging|May 15, 2015
Dosimetry of [(177)Lu]-DO3A-VS-Cys(40)-Exendin-4 - impact on the feasibility of insulinoma internal radiotherapyIrina Velikyan, Thomas N Bulenga, Ramkumar Selvaraju, et al.
Pageof 10